2025 AOCS Annual Meeting & Expo.
Lipid Oxidation and Quality
Health and Nutrition
Analytical
Marc Pignitter, PhD
Professor
University of Vienna, Physiological Chemistry
Wien, Wien, Austria
Fawzan Aurum
PhD
University of Vienna, Austria
Matthias Strauss
PhD student
University of Vienna, Austria
Yifan Bao, MSc
PhD student
University of Vienna
Wien, Wien, Austria
Julia Rogozinski
Master student
University of Vienna, Austria
Lukas Meusburger
Master student
University of Vienna, Austria
Christiane Ott
senior scientist
German Institute of Human Nutrition, Germany
Markus Gassner
PhD student
University of Vienna, Austria
Daniel König
Professor
University of Vienna, Austria
Tilman Grune
Professor
German Institute of Human Nutrition, Germany
Lipidomics provides critical insights into the relationship between lipid oxidation, intestinal health, and systemic oxidative stress. This study combines animal and human models to evaluate the potential of optimized flaxseed oil, enriched in natural antioxidants, in promoting intestinal metabolic health and mitigating oxidative stress.
In an animal model, the effects of fresh and stored conventional and optimized flaxseed oil on intestinal fatty acid oxidation (FAO) were investigated. Targeted LC-MS analysis revealed no significant changes in acylcarnitine levels in the jejunum. However, in the colon, fresh optimized flaxseed oil reduced total acylcarnitine content by ~50% compared to conventional oil, suggesting improved mitochondrial FAO efficiency and fewer pro-inflammatory lipid intermediates. Importantly, storage did not significantly alter acylcarnitine levels, highlighting the intrinsic oxidative stability of the optimized oils.
In a complementary human study, optimized flaxseed oil was shown to counteract exercise-induced oxidative stress. Targeted and untargeted lipidomics revealed significantly lower levels of oxidized phosphatidylcholines and oxysterols, including 7-ketocholesterol, in participants supplemented with the oil compared to controls. Increased plasma phospholipid content in the flaxseed oil group suggested reduced lipid oxidation susceptibility.
These findings highlight the dual role of optimized flaxseed oil in mitigating intestinal inflammation through improved FAO in animals and reducing systemic oxidative stress in humans. Lipidomics-enabled insights into lipid oxidation and metabolism underscore the potential of antioxidant-enriched oils to improve intestinal and systemic health, with implications for inflammatory conditions such as IBD and broader metabolic disorders.